Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Brain training may ease chemo fog in breast cancer patients

NCT ID NCT07570251

Symptom relief Sponsor: Saglik Bilimleri Universitesi Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether cognitive education activities could help breast cancer patients who experience memory, attention, and thinking problems after chemotherapy, often called 'chemobrain'. 108 patients took part. The activities were designed to support memory, attention, and executive function. The goal was to see if these exercises could improve cognitive function, reduce depression, and help with odor recognition.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

108 people

The number who actually took part.

Started

Mar 2025

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Participants were eligible if they met all of the following criteria: * Aged between 18 and 65 years * Literate * Diagnosed with breast cancer * Had received at least one cycle of chemotherapy and were currently undergoing chemotherapy * Had a Standardized Mini-Mental Test (SMMT) score of 24 or below * Had no diagnosed cognitive, neurological, or psychiatric disorder prior to chemotherapy Exclusion Criteria: Participants were excluded if they met any of the following criteria: * Age over 65 years * SMMT score above 24 * Presence of brain metastases * Presence of neurological or medical conditions affecting cognitive function * Diagnosed psychiatric disorder * Current use of central nervous system depressants, stimulants, or psychiatric medications * History of alcohol or substance abuse Withdrawal Criteria: Participants were withdrawn from the study if any of the following occurred: * Discontinuation of chemotherapy treatment * Inability to attend follow-up visits regularly * Failure to complete the cognitive activity booklet tasks * Loss of contact or inability to reach the participant * Voluntary withdrawal from the study * Death during the study period

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm Chemotherapy-Related Cognitive Impairment Depression

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer Chemotherapy-related cognitive impairment

Contacts and locations

Locations

  • Health Sciences University Gulhane Training and Research Hospital

    Ankara, Etlik, 06010, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.